Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting menu, I'll take it all !
Let us hope the NWBO-presentation is as yummy as well.
Saturday's Annual General Meeting does not seem to have been well received, if one considers the reaction on the German trading venues to be relevant.
This is probably mainly due to the statements on the status of the approval procedure, because unfortunately nothing concrete could or would be reported here. According to a transcript from an iHub user, the company does not even seem to know whether this "150-day review process" (which, as described several times, takes much longer than 150 days after an accepted application for approval anyway) is now being used or not. In addition, further queries are expected from the licensing authority.
All in all, unfortunately, new uncertainties and my hopelessly optimistic assessment from the last posting, that one can now expect a decision on the application for approval at any time or that this will be made in the next three or four months, has probably proven to be wrong.
If I interpret the statements now, which, as I said, I only know second-hand from some iHub postings, three to four months of waiting time are more likely to be the best-case scenario and it is more likely to be late autumn or winter before the MHRA decision is likely to be made at the earliest. However, it is more likely that it will not be until next year.
But for the permanent optimists, this development should bring new reason to rejoice, as they can now add to it really cheaply. his is the view of a german NWBO-shareholder :
https://www.wallstreet-online.de/diskussion/1325306-1-10/nwbo-northwest-biotherapeutics-inc-paradigmenwechsel-biotech-phase-3-results#beitrag_76026310
Shareprice in Germany is down 12.5% at the time of this posting.
Born decades ago and you know nothing but negativity !
1. Yes
2. Several
3. No
Interesting data !
But if the highest premium paid ( 667 % ) would be
applied to a BO for NWBO today, we'd end up with about $ 3.
Is that what we want and what it is worth ?
So you and the vast majority on this board ( minus some idiots ) believe what you wrote in your post, yes !
But are we the only ones ? What about all these scientists, BP-Execs, analysts ... ?
Don't they understand it ?
So I keep hammering my point again and again : Why has no company with very deep pockets
come up with an absolutely irresistible offer to take ofer NWBO ? Even an unfriendly take-over ?
What is it I do not get ?
Do I get something wrong here ?
If the presentation took place in 2022 you firmly
can say it took place before the approval. NO ?
Your learningcurve is NOT very steep, actually it's declining :
This company will start trials soon, so they start soon with P1.
How long will it take them to come up with results from this first phase ?
Are you aware what follows P1 ? Other phases that will take several years, so please come back
in let's say 5 years ?
Have you now learned something ? Most likely NOT !!!
Your posts and moral are already there, so
nothing to worry !
That's a nice response and how it could be / could have been, BUT
I don't think it is that simple and straightforward.
There must be - in my sceptical view - more, much more behind it -
that we still are below 50 cents and sitting on such a jewel, that will change
the medical world !
Gary
with all due respect for your positive postings, unbroken optimism and
deep insights into NWBO, just let me ask a very simple and fundamental
question :
Why hasn't BigPharma not already a long time ago submitted an irrestitibel
BuyOut-offer ?
Why would they wait until after approval (Wherever) when
shareprice goes up to $5, $10 or even more and not do it now for
a few $'s, say 3-4 ?
Is BP seeing / knowing something we don't and that's why they do not act NOW ?
Pls tell me ! TIA
Brilliant response ! ! !
What would this board do without you ?
That would be highly appreciated, but what brings you to this conclusion ?
Do have some compelling arguments, any hints ? TIA
Thanks. At least a reasonable and differentiated view and not
just hooray !
Why wasting your time with someone who wastes his time ?
Or do you just trying to play the board-guru and self-appointed
board-police ?
NO REPLY NEEDED !
Makes sense, along the lines of "The man in the white suit" (Movie)
Thanks for this link to Hoffmann's write-up, an excellent piece of work, but I remain
sceptical :
Why don't all these people from BP - Doctors, Scientists, PHD's and Researchers, those CEO's
who have to deliver growth and profits - see thru the fog of market manipulation ?
Why did BP not already a long time ago put their hands -or at least some fingers - on this developping
jewel ?
The past has shown that many, many billions of $ have been invested for the aquisition of small Biotechs with 1-2 products in early stages and no guarantee of approval ?
Why not here, what is wrong ?
So, the gist of the last 100 posts or so is simple :
Almost EVERY BP-company (Roche, AZN, J&J, GSK, Amgen ...) must aquire NWBO because they all want to cure cancer (who not ?) and according to this board, NWBO has that cure.
The disconnect to above statement is NWBO's current SP of 0.52.
If only one BP would be SERIOUSLY looking @ NWBO, SP should be much much higher, simply because of the Biotech rumor-mill. Just take the recent aquisition of Alpine for more than $ 4 Bill. with one product in P II.
Can anyone explain ?
Once it is approved, you become a FAILED poster !
Let me explain this for you : Even if you have him on ignore, he still can continue
to post. It's only you who will not see his posts anymore longer. Got that ?
(And congrats for being the boards spell-checker. Brilliant job !)
Pls work on your reading comprehension.
Then check out the diff unapproved / unproved.
Then you can come back to me.
I highly doubt that the doctors who take care of the King dare to use
an unapproved treatment. It's for THE KING and not just somebody from the street.
So, which other treatment could it be ? Which treatment comes close to the characteristics described in this bulletin ?
Are there any former DENDREON-Investors on this board ?
I was and if I remember correctly DNDN around approval investigated something similar
to Flaskworks : Every doctor and every hospital should be put in a position to produce Provenge
locally and for themselves. This project ultimately failed and I think this was the start of DNDN's demise.
Anyone has some memories to that ?
Inquirig
I feel so sorry for you that you had to go into BK !
What went wrong ?
Didn't your basher friends pay per negative-post as contracted?
Can anyone please point me to a description (easy to understand and practical)
about FLASKWORKS ?
TIA
This was exactly always my reasonig FOR a buy-out.
Why would a co. not recruit once they have submitted an MAA and have every reason to believe it will get approved ?
Once approval is here to start only then to recruit would be far to late to go it alone.
That would be my take on this.
30 days after submission to FDA :
Project Orbis Types
Orbis Type Type A Type B Type C
Submission Timeline
A) Application submission to POPs = 1 month of FDA submission
B) Application submission to POPs > 1 month of FDA submission
C) Any time after FDA submission2
Just an idea about the delay I posted a few days ago :
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173588871
Long-term NWBO-Investor / lurker - First time poster)
Observation : On Nov. 20 2023 MHRA annouced the released the availability of IRP
( International Recognition Procedure)
On Nov. 22 2023 NWBO thru a PR informed that the submission of it's MAA gets further delayed,
as their publisher needs more time to integrate certain things and complete
the 'package'
Could it be that the delay was due to the incorporation of these new IRP-Procedures and that NWBO's MAA is now running under those principles ?
https://www.gov.uk/government/news/mhra-launches-online-eligibility-checker-tool-for-applications-via-the-new-international-recognition-procedure-irp
https://finance.yahoo.com/news/northwest-biotherapeutics-provides-final-preparations-143000103.html
(Long-term NWBO-Investor / lurker - First time poster)
Observation : On Nov. 20 2023 MHRA annouced the released the availability of IRP
( International Recognition Procedure)
On Nov. 22 2023 NWBO thru a PR informed that the submission of it's MAA gets further delayed,
as their publisher needs more time to integrate certain things and complete
the 'package'
Could it be that the delay was due to the incorporation of these new IRP-Procedures and that NWBO's MAA is now
running under those principles ?
https://www.gov.uk/government/news/mhra-launches-online-eligibility-checker-tool-for-applications-via-the-new-international-recognition-procedure-irp
https://finance.yahoo.com/news/northwest-biotherapeutics-provides-final-preparations-143000103.html